ADDING ADDITIVE NALBUPHINE TO LEVOBUPIVACAINE IN UPPER LIMB SURGERIES
Not Applicable
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2023/03/050281
- Lead Sponsor
- MONISHA T S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA I to II Patients of either sex.
Aged between 20 to 60 years and weight >45kg.
Undergoing hand surgeries.
Exclusion Criteria
Patients with history of allergy to local Anaesthetics.
Patients with history of mental disorders.
Patient Refusal.
Morbid obesity, Coagulopathy and significant cardiovascular respiratory, renal, hepatic or metabolic diseases or CNS disorders.
Infection at site of procedure.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of analgesia. <br/ ><br>Timepoint: VAS at 0,1,2,4,8,12 and 24hrs
- Secondary Outcome Measures
Name Time Method 1) The onset and duration of sensory blockade. <br/ ><br>2) The onset and duration of motor blockade. <br/ ><br>3) Time for first analgesic request. <br/ ><br>4) side effects(if any). <br/ ><br> <br/ ><br>Timepoint: Asessed at 5,10,15,30,45,60,90 min intraoperatively and 1,2,4,8,12 and 24hrs postoperatively. <br/ ><br>